Parker Institute for Cancer Immunotherapy
In research, Parker Institute for Cancer Immunotherapy stands highest in Life Sciences (#293 of 7,800 worldwide), Medicine (#2,386 of 10,443 worldwide) and Health Sciences (#3,386 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Immunology, Oncology and Immunology and Microbiology — Immunology is 35.0× its share of world research.
- World rank, 2022–2025
- #945 of 28,054 · #1,774 all time
- Rank in United States
- #167 of 4,192
- Research works
- 385 ▲ 496% vs 2013–17
- Citations
- 40k 104.1 per fractional work
- Top-10% rate
- 50.1% record average 16.5%
- Open access
- 78% world 28%
What is Parker Institute for Cancer Immunotherapy known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| Life SciencesDomain | #293 of 7,800 | 54.1% | 83 | #663 | |
| MedicineField | #2,386 of 10,443 | 44.0% | 82 | #3588 | |
| Health SciencesDomain | #3,386 of 11,982 | 43.9% | 82 | #4976 |
Each strip is that field’s whole ranked pool, with the notch where Parker Institute for Cancer Immunotherapy sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Which of those standings moved
The same fields on both windows: where it stood over the whole record, and where it stands in 2022–2025. The distance is the story, and it is the one thing the two rank columns above cannot show.
- Life Sciences#663 #293
- Medicine#3,588 #2,386
- Health Sciences#4,976 #3,386
A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.
What does Parker Institute for Cancer Immunotherapy specialise in?
Where its research is concentrated relative to its size: Immunology takes 35.0× the share of its output that it takes of world research.
- ImmunologySubfield · 41.9 works35×
- OncologySubfield · 47.8 works24×
- Immunology and MicrobiologyField · 42.2 works24×
- Molecular BiologySubfield · 25.2 works4.8×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 24.1×. Every wedge is a field page.
- Immunology and Microbiology 24.1×
- Biochemistry, Genetics and Molecular Biology 4.1×
- Medicine 2.4×
- Veterinary 0.7×
- Pharmacology, Toxicology and Pharmaceutics 0.7×
- Neuroscience 0.7×
- Nursing 0.3×
- Chemistry 0.3×
- Engineering 0.3×
- Agricultural and Biological Sciences 0.1×
- Health Professions 0.1×
- Materials Science 0.1×
- Economics, Econometrics and Finance 0.0×
- Psychology 0.0×
- Environmental Science 0.0×
- Decision Sciences 0.0×
- Computer Science 0.0×
- Business, Management and Accounting 0.0×
Which keywords describe research at Parker Institute for Cancer Immunotherapy?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer Immunotherapy, Immunotherapy, Tumor Regression, Lymphoma, CAR T Cells, Chimeric Antigen Receptor, Tumor Microenvironment and Immunity.
- Recombinant Protein
- Mammalian Cells
- Targeted Therapy
- Macrophage
- Viral Vectors
- AAV
- Single-Cell
- Glycosylation
- Foxp3
- Autoimmunity
- Gene Expression
- Cancer
- Tumor Antigen
- Antigen Presentation
- Natural Killer Cells
- PD-1 and PD-L1
- Immunity
- Chimeric Antigen Receptor
- Lymphoma
- Immunotherapy
- Cancer Immunotherapy
- Tumor Regression
- CAR T Cells
- Tumor Microenvironment
- Immune Checkpoint Blockade
- NK Cell Recognition
- Innate Immunity
- Dendritic Cells
- Vaccine Adjuvants
- Inflammation
- TGF-ß
- CD4+CD25+
- Gene Therapy
- RNA-Seq
- Transcriptomics
- Metabolism
- Activation
- Monoclonal Antibodies
- Genome Engineering
- RNA-Guided
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Cancer Immunotherapy39▲ 146×3 topics
- Immunotherapy37▲ 30×14 topics
- Tumor Regression30▲ 156×2 topics
- Lymphoma30▲ 105×3 topics
- CAR T Cells28▲ 223×1 topic
- Chimeric Antigen Receptor28▲ 223×1 topic
- Tumor Microenvironment19▲ 24×8 topics
- Immunity16▲ 23×7 topics
- Immune Checkpoint Blockade14▲ 73×1 topic
- PD-1 and PD-L114▲ 73×1 topic
- NK Cell Recognition14▲ 119×1 topic
- Natural Killer Cells14▲ 119×1 topic
- Innate Immunity13▲ 24×8 topics
- Antigen Presentation12▲ 76×2 topics
- Dendritic Cells10▲ 66×2 topics
- Tumor Antigen10▲ 93×1 topic
- Vaccine Adjuvants10▲ 93×1 topic
- Cancer10▲ 4.2×24 topics
- Inflammation8▲ 2.4×30 topics
- Gene Expression8▲ 7.9×9 topics
- TGF-ß8▲ 30×3 topics
- Autoimmunity8▲ 31×4 topics
- CD4+CD25+7▲ 123×1 topic
- Foxp37▲ 123×1 topic
- Gene Therapy7▲ 20×3 topics
- Glycosylation6▲ 31×3 topics
- RNA-Seq5▲ 27×2 topics
- Single-Cell5▲ 65×1 topic
- Transcriptomics5▲ 65×1 topic
- AAV4▲ 59×1 topic
- Metabolism4▲ 4.5×3 topics
- Viral Vectors4▲ 59×1 topic
- Activation4▲ 38×1 topic
- Macrophage4▲ 31×1 topic
- Monoclonal Antibodies4▲ 23×2 topics
- Targeted Therapy4▲ 9.4×5 topics
- Genome Engineering3▲ 30×1 topic
- Mammalian Cells3▲ 79×1 topic
- RNA-Guided3▲ 30×1 topic
- Recombinant Protein3▲ 79×1 topic
Which research topics does Parker Institute for Cancer Immunotherapy publish most on?
By volume in 2022–2025: CAR-T cell therapy research, Cancer Immunotherapy and Biomarkers, Immune Cell Function and Interaction and Immunotherapy and Immune Responses.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 CAR-T cell therapy researchOncology 28 works
- 2 Cancer Immunotherapy and BiomarkersOncology 14 works
- 3 Immune Cell Function and InteractionImmunology 14 works
- 4 Immunotherapy and Immune ResponsesImmunology 10 works
- 5 T-cell and B-cell ImmunologyImmunology 7 works
- 6 Single-cell and spatial transcriptomicsMolecular Biology 5 works
- 7 Virus-based gene therapy researchGenetics 4 works
- 8 Immune cells in cancerImmunology 4 works
- 9 Viral Infectious Diseases and Gene Expression in InsectsMolecular Biology 3 works
- 10 CRISPR and Genetic EngineeringMolecular Biology 3 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Parker Institute for Cancer Immunotherapy's research output changed?
Output in 2018–2022 was 496% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in San Francisco
- University of California, San Francisco
- San Francisco State University
- University of San Francisco
- San Francisco VA Medical Center
- University of California San Francisco Medical Center
- San Francisco General Hospital
- Institute on Aging
- California Pacific Medical Center
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.